DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 117 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q1 2020. The put-call ratio across all filers is 0.75 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $2,597,624 | +77.3% | 209,317 | +101.0% | 0.01% | +900.0% |
Q4 2021 | $1,465,000 | -31.9% | 104,121 | -7.0% | 0.00% | -50.0% |
Q3 2021 | $2,151,000 | +264.6% | 111,962 | +86.8% | 0.00% | +100.0% |
Q2 2021 | $590,000 | +164.6% | 59,934 | +164.1% | 0.00% | – |
Q1 2021 | $223,000 | -43.3% | 22,693 | -74.3% | 0.00% | -100.0% |
Q4 2020 | $393,000 | +73.9% | 88,424 | +69.0% | 0.00% | 0.0% |
Q3 2020 | $226,000 | -41.3% | 52,324 | +20.5% | 0.00% | -50.0% |
Q2 2020 | $385,000 | +266.7% | 43,416 | +45.7% | 0.00% | +100.0% |
Q1 2020 | $105,000 | +19.3% | 29,802 | +20.9% | 0.00% | 0.0% |
Q3 2019 | $88,000 | -64.2% | 24,643 | -60.0% | 0.00% | -50.0% |
Q2 2019 | $246,000 | -76.7% | 61,586 | -57.4% | 0.00% | -83.3% |
Q1 2019 | $1,056,000 | +49.4% | 144,426 | +87.0% | 0.01% | +100.0% |
Q4 2018 | $707,000 | +32.4% | 77,252 | +79.3% | 0.01% | +50.0% |
Q3 2018 | $534,000 | -53.0% | 43,077 | -42.2% | 0.00% | -60.0% |
Q2 2018 | $1,137,000 | -29.8% | 74,583 | -8.6% | 0.01% | -37.5% |
Q1 2018 | $1,619,000 | +26.7% | 81,576 | +19.3% | 0.02% | +77.8% |
Q4 2017 | $1,278,000 | -18.7% | 68,355 | -58.0% | 0.01% | -43.8% |
Q2 2017 | $1,571,000 | +32.8% | 162,799 | -18.1% | 0.02% | +14.3% |
Q1 2017 | $1,183,000 | -20.6% | 198,840 | +94.6% | 0.01% | -22.2% |
Q2 2016 | $1,490,000 | -24.0% | 102,189 | +0.3% | 0.02% | -35.7% |
Q1 2016 | $1,960,000 | +77.7% | 101,855 | +123.2% | 0.03% | +115.4% |
Q4 2015 | $1,103,000 | +36.5% | 45,637 | +38.5% | 0.01% | +18.2% |
Q3 2015 | $808,000 | -30.8% | 32,940 | -33.9% | 0.01% | -31.2% |
Q2 2015 | $1,168,000 | – | 49,841 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bain Capital Life Sciences Investors, LLC | 10,895,773 | $47,070,000 | 4.39% |
DC Investments Management, LLC | 196,799 | $850,000 | 0.93% |
Chicago Capital, LLC | 3,930,524 | $16,980,000 | 0.87% |
PFM Health Sciences, LP | 2,936,990 | $12,688,000 | 0.59% |
Avidity Partners Management LP | 2,025,000 | $8,748,000 | 0.41% |
Soleus Capital Management, L.P. | 167,798 | $725,000 | 0.38% |
Rhenman & Partners Asset Management AB | 925,534 | $3,998,000 | 0.36% |
Haafor (Singapore) Pte. Ltd. | 27,128 | $117,000 | 0.24% |
JACKSON SQUARE CAPITAL, LLC | 122,555 | $529,000 | 0.23% |
Parkman Healthcare Partners LLC | 200,000 | $864,000 | 0.23% |